Perrigo (NYSE:PRGO) Reaches New 1-Year Low – What’s Next?

Shares of Perrigo Company plc (NYSE:PRGO) hit a new 52-week low on Friday . The stock traded as low as $9.23 and last traded at $9.2450, with a volume of 5586251 shares. The stock had previously closed at $9.65.

Analyst Upgrades and Downgrades

PRGO has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. cut their target price on shares of Perrigo from $20.00 to $18.00 and set a “neutral” rating on the stock in a research note on Monday, December 15th. Zacks Research upgraded Perrigo from a “strong sell” rating to a “hold” rating in a research note on Friday, February 13th. Canaccord Genuity Group lowered their price objective on Perrigo from $20.00 to $17.00 and set a “buy” rating for the company in a report on Friday, February 27th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Perrigo in a report on Monday, December 22nd. Finally, Argus upgraded Perrigo to a “hold” rating in a research report on Wednesday, January 14th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Perrigo presently has an average rating of “Hold” and an average target price of $19.33.

Perrigo Stock Performance

The stock’s 50-day moving average price is $13.40 and its 200-day moving average price is $16.21. The company has a current ratio of 2.76, a quick ratio of 1.63 and a debt-to-equity ratio of 1.23. The company has a market capitalization of $1.27 billion, a P/E ratio of -0.90, a P/E/G ratio of 1.19 and a beta of 0.41.

Perrigo (NYSE:PRGO) last announced its quarterly earnings data on Thursday, February 26th. The company reported $0.77 earnings per share for the quarter, missing analysts’ consensus estimates of $0.80 by ($0.03). The business had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.09 billion. Perrigo had a negative net margin of 33.51% and a positive return on equity of 9.41%. Perrigo’s quarterly revenue was down 2.5% on a year-over-year basis. During the same period in the prior year, the company earned $0.93 EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, equities analysts expect that Perrigo Company plc will post 2.56 EPS for the current year.

Perrigo Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 24th. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.29 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $1.16 annualized dividend and a dividend yield of 12.5%. Perrigo’s dividend payout ratio is -11.28%.

Institutional Trading of Perrigo

Several hedge funds have recently made changes to their positions in the stock. Bahl & Gaynor Inc. increased its stake in shares of Perrigo by 5.4% in the third quarter. Bahl & Gaynor Inc. now owns 2,087,075 shares of the company’s stock valued at $46,479,000 after purchasing an additional 107,774 shares during the period. Cooke & Bieler LP boosted its position in shares of Perrigo by 11.6% during the third quarter. Cooke & Bieler LP now owns 3,680,411 shares of the company’s stock worth $81,963,000 after buying an additional 381,290 shares during the period. Diamond Hill Capital Management Inc. grew its holdings in Perrigo by 8.6% in the 3rd quarter. Diamond Hill Capital Management Inc. now owns 1,797,746 shares of the company’s stock worth $40,036,000 after buying an additional 142,363 shares in the last quarter. Nicola Wealth Management LTD. grew its holdings in Perrigo by 38.4% in the 3rd quarter. Nicola Wealth Management LTD. now owns 281,000 shares of the company’s stock worth $6,257,000 after buying an additional 78,000 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its position in Perrigo by 2.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 7,695,238 shares of the company’s stock valued at $171,367,000 after acquiring an additional 181,828 shares during the period. Institutional investors own 95.91% of the company’s stock.

About Perrigo

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.